Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in …
DY Logunov, IV Dolzhikova, DV Shcheblyakov… - The Lancet, 2021 - thelancet.com
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1 …
…, OV Zubkova, AI Tukhvatulin, DV Shcheblyakov… - The Lancet, 2020 - thelancet.com
Background We developed a heterologous COVID-19 vaccine consisting of two components,
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
Neutralizing activity of sera from Sputnik V-vaccinated people against variants of concern (VOC: B. 1.1. 7, B. 1.351, P. 1, B. 1.617. 2, B. 1.617. 3) and Moscow endemic …
…, DM Grousova, AI Tukhvatulin, DV Shcheblyakov… - Vaccines, 2021 - mdpi.com
Since the beginning of the 2021 year, all the main six vaccines against COVID-19 have
been used in mass vaccination companies around the world. Virus neutralization and …
been used in mass vaccination companies around the world. Virus neutralization and …
[HTML][HTML] An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus …
…, IV Dolzhikova, DV Shcheblyakov… - The Lancet Regional …, 2021 - thelancet.com
Background While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV-and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
…, NM Tukhvatulina, DV Shcheblyakov… - Human vaccines & …, 2017 - Taylor & Francis
Ebola hemorrhagic fever, also known as Ebola virus disease or EVD, is one of the most
dangerous viral diseases in humans and animals. In this open-label, dose-escalation clinical trial…
dangerous viral diseases in humans and animals. In this open-label, dose-escalation clinical trial…
Virus-vectored Ebola vaccines
…, AI Tukhvatulin, DV Shcheblyakov… - Acta Naturae …, 2017 - cyberleninka.ru
The Ebola virus disease (EVD) is one of the most dangerous infections affecting humans
and animals. The first EVD outbreaks occurred in 1976 in Sudan and Zaire. Since then, more …
and animals. The first EVD outbreaks occurred in 1976 in Sudan and Zaire. Since then, more …
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
…, AS Erokhova, DV Shcheblyakov… - Emerging Microbes & …, 2022 - Taylor & Francis
Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
Retention of neutralizing response against SARS-CoV-2 omicron variant in sputnik V-Vaccinated individuals
…, AV Kovyrshina, IV Dolzhikova, DV Shcheblyakov… - Vaccines, 2022 - mdpi.com
The new Omicron variant of SARS-CoV-2, first identified in November 2021, is rapidly spreading
all around the world. Omicron has become the dominant variant of SARS-CoV-2. There …
all around the world. Omicron has become the dominant variant of SARS-CoV-2. There …
Camelid VHHs fused to human fc fragments provide long term protection against botulinum neurotoxin a in mice
…, DY Logunov, BS Naroditsky, DV Shcheblyakov… - Toxins, 2019 - mdpi.com
The bacterium Clostridium botulinum is the causative agent of botulism—a severe intoxication
caused by botulinum neurotoxin (BoNT) and characterized by damage to the nervous …
caused by botulinum neurotoxin (BoNT) and characterized by damage to the nervous …
Single-domain antibodies efficiently neutralize SARS-CoV-2 variants of concern
IA Favorskaya, DV Shcheblyakov… - Frontiers in …, 2022 - frontiersin.org
Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution
of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to …
of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to …
